Find a Tender Service

Vascular Therapy and Associated Products 2028

Supply Chain Coordination Limited

Live
Confirmed tender
goods
Framework agreement
2 lots

Supply Chain Coordination Limited is looking for a supplier of goods: Vascular Therapy and Associated Products 2028. Category: Medical consumables. Estimated value £96,630,000. Bids close on 19 Jan 2027. Region: London. Procedure: Open procedure.

Get tenders like this by email

New tenders like this one, in your inbox every morning. Starts with 14 days of Pro, no card needed.

Unsubscribe in one click. See our privacy policy.

Key details

Contracting authority
Supply Chain Coordination Limited
Public authority - sub-central government
Region
London
Delivery: United Kingdom, United Kingdom
Contract value
£96,630,000ex VAT
£115,956,000 inc VAT
Deadline
19 January 2027
Enquiry deadline
12 January 2027(questions / clarifications)
Award decision
21 July 2027(estimated)
Published
18 November 2026

More tenders like this

Procurement

Contract period
28 February 2028 - 27 February 2030
2 years
Possible extension to 27 February 2032 · 3 years, 11 months in total
Extension terms: The initial framework term will be 24 months. NHS Supply Chain may, at its sole discretion, extend the framework by up to two further periods of 12 months each, giving a maximum framework duration of 48 months.
Procedure type
Open procedure
CPV classifications

Description

NHS Supply Chain seeks to establish a framework agreement for the supply of Vascular Therapy and Associated Products.

The framework will provide a range of products for acute and chronic vascular therapy requirements and is divided into two Lots:

Lot 1: Acute Therapy Products

Lot 2: Chronic Therapy Products

Tenderers may tender for one or both Lots.

The framework will support NHS Supply Chain and its customers through applicable routes of supply, including Stocked, eDirect and Direct routes, as further described in the procurement documents.

The framework will be available for use by NHS Trusts, other NHS entities, government departments, agencies and other statutory bodies, including local authorities, and private sector entities active in the UK healthcare sector, in accordance with the procurement documents.

The anticipated value of the Framework Agreement for the initial twenty-four (24) month term is approximately £46,230,000 excluding VAT. The Authority may extend the Framework Agreement by up to two further periods of twelve (12) months each. The anticipated total value over the maximum forty-eight (48) month term, including the extension options, is approximately £96,630,000 excluding VAT.

These values are estimates based on historical usage and forecast demand and do not constitute a guarantee of expenditure or business under the Framework Agreement.

How to engage

This PME is intended to consult the market and identify potential suppliers capable of meeting the Authority’s emerging requirements for Vascular Therapy products and associated services. Through this engagement, the Authority aims to: • understand supplier capacity and capability; • explore opportunities for innovation; • ensure transparency and awareness of the potential opportunity across the market; and • inform the design of a future procurement approach that is proportionate, competitive and aligned with NHS Trust requirements. ________________________________________ Understanding current direct routes to market As part of this PME, the Authority specifically wishes to engage with suppliers to better understand the current direct route to market commercial models operating within the Vascular Therapy category. At present, NHS Supply Chain has limited visibility of how products and services are sold directly to NHS Trusts, including: • commercial and pricing structures; • contracting and ordering mechanisms; • the role of services, training or education within direct sales models; and • how these arrangements operate in practice for Trusts. Gaining this insight will support the development of a robust and transparent commercial strategy, inform the design and structure of any future framework arrangement, and help ensure alignment with existing Trust purchasing behaviours and prevailing market practice. ________________________________________ Scope of the Preliminary Market Engagement The PME will include the following activities: • Expression of Interest (EOI) Interested suppliers are invited to submit an Expression of Interest (EOI) via the Jaggaer eProcurement Portal. Interested suppliers can express interest in the opportunity using the following link: PORTAL ACCESS • Login with URL • Click on “SQs Open to All Suppliers” and search for the title of the procurement: Project_1753 - Vascular Therapy and Associated Products 2028 Pre Market Engagement EXPRESSION OF INTEREST • Click on the ‘EXPRESS INTEREST’ button in the top right corner. • Answer the question in the Qualification Envelope. • The deadline for submission of EOIs is 30 June 2026. • 1 to 1 Supplier Meetings Optional 1 to 1 supplier meetings will be offered during June/July 2026 to suppliers who have expressed interest. These sessions will allow for structured discussion on the emerging Vascular Therapy procurement and are expected to cover: 1. Products and specifications 2. Training and educational offerings 3. Supply chain resilience and continuity plans 4. Sustainability requirements 5. Commercial and route‑to‑market models (including direct sales arrangements with NHS Trusts), and any other matters relevant to the potential procurement • Ongoing Engagement and Feedback Further engagement meetings may be held to gather feedback on the draft specification and/or product list. This engagement is expected to continue up until the end of August 2026, to support the completion and refinement of requirements. ________________________________________ Draft Documentation and Feedback • Suppliers who submit an EOI will be provided with draft specifications and a draft product list, which are currently under development. • This is expected to take place during July–August 2026 (subject to change). • The Authority will invite feedback, comments and assumptions based on these draft documents to inform the final procurement design. ________________________________________ Nature of Engagement • The Authority will maintain dialogue with incumbent suppliers and engage with potential new suppliers who express interest, initiating exploratory discussions to understand supplier offerings and assess alignment with emerging requirements. • Engagement may take place via Microsoft Teams, telephone or face to face meetings, subject to suitability and availability. • Suppliers who express an interest are encouraged to engage constructively through the engagement opportunities offered as part of this PME. ________________________________________ Important Notices • This Preliminary Market Engagement does not constitute a commitment by the Authority to commence a formal procurement process or to award any contract(s). ________________________________________ The Authority sincerely appreciates supplier engagement and looks forward to receiving considered input throughout the course of this PME.

Contact

Address
Wellington House, 133-155 Waterloo Road, London, SE1 8UG

Bid documents

Track this tender with a free account to open its bid documents.

Identifiers

Buyer reference
Project_1753
Notice ID
109328-2026
OCID
ocds-h6vhtk-0687ac

Explore related tenders

External ID: fts-ocds-h6vhtk-0687ac • Added 21 April 2026

Get tenders like these by email

Tell us what you do and where you work. Every morning you get the new tenders that fit, from national portals and the buyer portals most services miss.

14 days of Pro, no card. Then Free unless you upgrade.